Risk of Transmitting Coronavirus Disease 2019 During Nebulizer Treatment: A Systematic Review.

ABSTRACT: Rationale: There is an urgent need to understand the risk of viral transmission during nebulizer treatment of patients with coronavirus disease 2019 (COVID-19). Objectives: To assess the risk of transmitting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), SARS, Middle East respiratory syndrome (MERS), and influenza with administration of drugs via nebulizer. Methods: We searched multiple electronic databases, including PubMed^®, China National Knowledge Infrastructure, Wanfang, preprint databases, and clinicaltrials.gov through December 1, 2020. Any study design in any language describing the risk of viral transmission with nebulizer treatment was eligible. Data were abstracted by one investigator and verified by a second. <

SUBMITTER: Goldstein KM 

PROVIDER: S-EPMC8336259 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature